Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3765197019 | Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3765198012 | Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3765199016 | Ethinyl estradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength denominator unit | hour | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength numerator value | 1.46 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has basis of strength substance | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has manufactured dose form | Prolonged-release transdermal patch | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Is a | Product containing only ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has precise active ingredient | Norelgestromin | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength numerator value | 6.25 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength denominator unit | hour | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Plays role | Contraceptive therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has precise active ingredient | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has basis of strength substance | Norelgestromin | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR